Clinuvel Pharmaceuticals Limited carries a market capitalization of 296.92M, placing it among publicly traded companies globally.
| Market Cap | 296.92M |
| Enterprise Value | N/A |
Clinuvel Pharmaceuticals Limited's stock has declined approximately -20.9396% over the past 52 weeks. The 50-day moving average sits at 6.46, while the 200-day moving average is 7.27.
| Beta (5Y) | N/A |
| 52-Week Price Change | -20.9396% |
| 50-Day Moving Average | 6.46 |
| 200-Day Moving Average | 7.27 |
| Average Volume (20 Days) | N/A |
Clinuvel Pharmaceuticals Limited's most recent stock split took place on November 18, 2010 with a 10:1 split ratio.
| Last Split Date | 11/18/2010 |
| Split Ratio | 10:1 |